Related Articles
MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
Clinical benefits of metformin in gynecologic oncology (Review)
Current findings on the antitumor effects of metformin on esophageal squamous cell carcinoma (Review)
Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer
New drugs are not enough‑drug repositioning in oncology: An update